NEU1 is a key driver of myocardial hypertrophy, and anti-influenza drugs zanamivir and oseltamivir (viral NEU inhibitors) can significantly alleviate myocardial hypertrophy (22). Here, NEU1 is linked to cardiac hypertrophy.